Cargando…

Extracellular signal regulated kinase 5 and inflammasome in progression of mesothelioma

Malignant mesothelioma is an aggressive cancer in desperate need of treatment. We have previously shown that extracellular signaling regulated kinase 5 (ERK5) plays an important role in mesothelioma pathogenesis using ERK5 silenced human mesothelioma cells exhibiting significantly reduced tumor grow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thompson, Joyce K., Shukla, Anurag, Leggett, Alan L., Munson, Phillip B., Miller, Jill M., MacPherson, Maximilian B., Beuschel, Stacie L., Pass, Harvey I., Shukla, Arti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787465/ https://www.ncbi.nlm.nih.gov/pubmed/29416614 http://dx.doi.org/10.18632/oncotarget.22968

Ejemplares similares

Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma
por: Westbom, Catherine, et al.
Publicado: (2015)

Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin
por: Shukla, Arti, et al.
Publicado: (2010)

Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells
por: Hillegass, Jedd M, et al.
Publicado: (2013)

Exosomal miR-16-5p as a target for malignant mesothelioma
por: Munson, Phillip B., et al.
Publicado: (2019)

Potential Roles of Exosomes in the Development and Detection of Malignant Mesothelioma: An Update
por: Munson, Phillip, et al.
Publicado: (2022)

Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation
por: Thompson, Joyce K, et al.
Publicado: (2014)

Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenografts
por: Macura, Sherrill L, et al.
Publicado: (2013)

Peroxiredoxin 3 Is a Redox-Dependent Target of Thiostrepton in Malignant Mesothelioma Cells
por: Newick, Kheng, et al.
Publicado: (2012)

Exosomes: Potential in Cancer Diagnosis and Therapy
por: Munson, Phillip, et al.
Publicado: (2015)

Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma
por: Cunniff, Brian, et al.
Publicado: (2015)

Heparanase inhibitors restrain mesothelioma
por: Lapidot, Moshe, et al.
Publicado: (2018)

Exploratory use of docetaxel loaded acid-prepared mesoporous spheres for the treatment of malignant melanoma
por: Kaiser, Sameer, et al.
Publicado: (2015)

Tsc1-Tp53 loss induces mesothelioma in mice, and evidence for this mechanism in human mesothelioma
por: Guo, Yanan, et al.
Publicado: (2013)

The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling
por: Roshini, Arivazhagan, et al.
Publicado: (2022)

Mechanisms of oxidative stress and alterations in gene expression by Libby six-mix in human mesothelial cells
por: Hillegass, Jedd M, et al.
Publicado: (2010)

National Mesothelioma Virtual Bank: A Platform for Collaborative Research and Mesothelioma Biobanking Resource to Support Translational Research
por: Amin, Waqas, et al.
Publicado: (2013)

Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma
por: Cioce, Mario, et al.
Publicado: (2021)

Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort
por: Amin, Waqas, et al.
Publicado: (2019)

Fra-1 governs cell migration via modulation of CD44 expression in human mesotheliomas
por: Ramos-Nino, Maria E, et al.
Publicado: (2007)

Development of a Biosensor for Detection of Pleural Mesothelioma Cancer Biomarker Using Surface Imprinting
por: Mathur, Aabhas, et al.
Publicado: (2013)

Evaluation of clonal origin of malignant mesothelioma
por: Comertpay, Sabahattin, et al.
Publicado: (2014)

Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches—a narrative review
por: Zolondick, Alicia A., et al.
Publicado: (2021)

Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo
por: Yang, Huanjie, et al.
Publicado: (2012)

Onconase Mediated NFKβ Down-Regulation in Malignant Pleural Mesothelioma
por: Goparaju, Chandra M., et al.
Publicado: (2011)

The promyelocytic leukemia zinc finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival
por: Cheung, Mitchell, et al.
Publicado: (2009)

Correction: Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo
por: Yang, Huanjie, et al.
Publicado: (2013)

Mechanisms of FUS1/TUSC2 deficiency in mesothelioma and its tumorigenic transcriptional effects
por: Ivanova, Alla V, et al.
Publicado: (2009)

Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma
por: Carbone, Michele, et al.
Publicado: (2016)

Disulfiram Suppresses Growth of the Malignant Pleural Mesothelioma Cells in Part by Inducing Apoptosis
por: Cheriyan, Vino T., et al.
Publicado: (2014)

Germline BAP1 mutations predispose to malignant mesothelioma
por: Testa, Joseph R., et al.
Publicado: (2011)

Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
por: Sato, Hiroki, et al.
Publicado: (2018)

Malignant mesothelioma presenting as dysphagia diagnosed by endoscopic ultrasound
por: Al-Bawardy, Badr, et al.
Publicado: (2014)

From Inflammasome to Exosome—Does Extracellular Vesicle Secretion Constitute an Inflammasome-Dependent Immune Response?
por: Cypryk, Wojciech, et al.
Publicado: (2018)

CARP-1 Functional Mimetics Are a Novel Class of Small Molecule Inhibitors of Malignant Pleural Mesothelioma Cells
por: Jamal, Shazia, et al.
Publicado: (2014)

FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model
por: Szymiczek, Agata, et al.
Publicado: (2017)

Extracellular Vesicles and the Inflammasome: An Intricate Network Sustaining Chemoresistance
por: Mezzasoma, Letizia, et al.
Publicado: (2022)

Supplementary Prognostic Variables for Pleural Mesothelioma: A Report from the IASLC Staging Committee
por: Pass, Harvey I., et al.
Publicado: (2014)

The interpretation of graphs in physics
por: MacPherson, I S, et al.
Publicado: (1974)

Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation
por: Cioce, M, et al.
Publicado: (2014)

Malignant Mesothelioma
por: Pouliquen, Daniel L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_58tvjusc4et1t86nr54263na70